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Human immunodeficiency virus (HIV) belongs to 
human retrovirus family and transmitted by blood 
transfusion and blood products. 36.9 million People 
were living with HIV infection worldwide in 2014 
approximately1, during which 2 million (1.9–2.2 
million) new infections with HIV had occurred. End-
stage renal disease (ESRD) patients treated by 
hemodialysis (HD) are more susceptible for infection 
by human immunodeficiency virus infection. Renal 
failure can be an associated condition or could be a 
direct consequence of HIV infection2,3. Advanced 
HIV disease which is indicates by a low CD4 cell 
count is development of renal diseases subsequently4, 
however many other causes now may cause renal 
failure in patients with HIV, including drug-induced 
toxicity, hypertensive nephroangiosclerosis, and 
diabetes5. HIV infection and hemodialysis have same 
consequences such as cardiovascular diseases, 
immunosuppression, anemia, weight loss, and 
osteodystrophy6,7.  
Compared with rate of infection with other viral 
infection such as hepatitis B virus (HBV) or hepatitis 
C virus (HCV), the risk of HIV infection among 
hemodialysis patients is lower as the contact with 
contaminated sources.  
Although intensive HIV research has been done for 
20 years, we have a little knowledge about mortality 
risk factor in ESRD on HIV-infected patients. 
Hemodialysis patients who have HIV-infected are 
assumed to a high risk for death4. 
The finding the current study demonstrated the 
prevalence of HIV in hemodialysis patients which was 
conducted in 5 hemodialysis centers in Tehran 
province, Iran, in the 2016. All the enrolled 
participants were informed about study and written 
informed consent was obtained. Statistical analysis 
was performed by SPSS version 16 (SPSS Inc, 
Chicago, IL, USA).   
Among 360 patients, 213 (59.17%) of patients were 
men and 147 (40. 83%) were females; the mean age of 
patients was 53.43. HIV Ab was negative in all cases. 
This result has been confirmed in other studies as 
well8. The highest frequency for duration of dialysis is 
1-5 years. 
Nowadays viral transmission via hemodialysis routes 
is controlled and limited since more effective 
screening of blood donor. Screening and early 
diagnosis of kidney disease will improve outcomes in 
patients with HIV infection.  
Considering all of these evidences, further studies are 
recommended strongly to evaluate the real prevalence 
of HIV in these patients. 
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